PhaseBio Pharmaceuticals (NASDAQ:PHAS) Trading 7% Higher

Retrieved on: 2019-06-13 08:45:00

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Trading 7% Higher. View article details on hiswai:

Excerpt

<div>Finally, <b>Schonfeld Strategic Advisors</b> LLC bought a new position in PhaseBio Pharmaceuticals during the 1st quarter worth $600,000. Hedge funds ...</div>

Article found on:

View Original Article